Ticker Details
Standard BioTools Inc.
IPO Date:	March 1, 2011
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$268.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 3.94%
Avg Daily Range (30 D):	$0.03 | 3.59%
Avg Daily Range (90 D):	$0.04 | 4.38%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	1.66M
Avg Daily Volume (90 D):	2.55M

Trade Size
Avg Trade Size (Sh.):	204
Avg Trade Size (Sh.) (30 D):	204
Avg Trade Size (Sh.) (90 D):	241

Institutional Trades
Total Institutional Trades:	138
Avg Institutional Trade:	$1.92M
Avg Institutional Trade (30 D):	$10.31M
Avg Institutional Trade (90 D):	$3.9M
Avg Institutional Trade Volume:	1.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.02M
Avg Closing Trade (30 D):	$19.53M
Avg Closing Trade (90 D):	$4.37M
Avg Closing Volume:	2.02M

News

Jun 19, 2026 @ 4:48 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 8, 2026 @ 11:30 AM Standard BioTools and Treeline Biosciences Announc... Source: Na

Apr 21, 2026 @ 11:00 AM Standard BioTools to Announce First Quarter 2026 F... Source: Na

Feb 10, 2026 @ 12:00 PM Standard BioTools to Announce Fourth Quarter and F... Source: Na

Jul 21, 2025 @ 11:00 AM Standard BioTools Schedules Second Quarter Earning... Source: Marissa Bychir

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.22	$-.07	$.33
Diluted EPS	$.22	$-.07	$.33
Revenue	$84.6M	$20.1M	$21.15M
Gross Profit	$42.71M	$10.54M	$11.31M
Net Income / Loss	$84.91M	$-26.76M	$127.07M
Operating Income / Loss	$-95.47M	$-25.39M	$-12.5M
Cost of Revenue	$41.89M	$9.57M	$9.84M
Net Cash Flow	$110.91M	$4.25M	$144.57M
PE Ratio